BOLT Bolt Biotherapeutics, Inc.

NASDAQ
$3.58

Bolt Biotherapeutics, Inc. (BOLT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus BOLT's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
2
2 transactions
Insiders selling
3
9 transactions
Purchases
$4.4K
1,146 shares
Sales
$128.3K
38,584 shares
Net activity
-$123.8K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $128.3K 9 transactions · 38,584 shares

Largest single sale: $29.6K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: June 5, 2026 , by Quinn William P. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Quinn William P. President, CEO and CFO Sell 9,132 $3.24 $29.6K 25,384 −26.5% of holding
Yonehiro Grant Chief Operating Officer Sell 6,850 $3.24 $22.2K 17,269 −28.4% of holding
Nemec Sarah Senior VP, Finance and PAO Sell 4,077 $3.24 $13.2K 17,082 −19.3% of holding
Quinn William P. President, CEO and CFO Sell 6,545 $3.32 $21.7K 34,516 −15.9% of holding
Yonehiro Grant Chief Operating Officer Sell 4,909 $3.32 $16.3K 24,119 −16.9% of holding
Nemec Sarah Senior VP, Finance and PAO Sell 2,922 $3.32 $9.7K 21,159 −12.1% of holding
Quinn William P. President, CEO and CFO Sell 1,889 $3.77 $7.1K 41,061 −4.4% of holding
Yonehiro Grant Chief Operating Officer Sell 1,417 $3.77 $5.3K 29,028 −4.7% of holding
Nemec Sarah Senior VP, Finance and PAO Sell 843 $3.77 $3.2K 24,081 −3.4% of holding
Quinn William P. President, CEO and CFO Buy 637 $3.88 $2.5K 2,950
Nemec Sarah Senior VP, Finance and PAO Buy 509 $3.88 $2.0K 1,924

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.